Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems

Sudden cardiac death remains a major cause of death in the industrialised world. Implantable cardioverter-defibrillators have been shown to be an effective therapy option for the primary prevention of SCD in patients at high risk of SCD. About sixty percent (60%) of ICDs are implanted for primary prevention, the remaining for secondary prevention. The treatment of patients largely depends on age, comorbidities and reason for implantation (primary vs. secondary prevention). The next report will be about Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems.
«Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems»
Anna Vereshchagina - PhD, cardiologist of the National Medical Research Center of Cardiology named after academician E.I. Chazov, Moscow, Russia
Другие доклады из вебинаров ЕВРА вы можете посмотреть здесь:
• Лекции из вебинаров ЕВРА
Полноценные трансляции вебинаров ЕВРА здесь:
• Вебинары ЕВРА
#кардиошеф #лечениеаритмии #рча
Социальные сети профессора:
Telegram: t.me/professor_ardashev
VK: professor_ardashev
Rutube: rutube.ru/channel/23959342/
ЗАПИСЬ НА ПРИЕМ:
www.aritmologi.com/
8 [phone]